Compare INVA & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVA | CET |
|---|---|---|
| Founded | 1996 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2000 | N/A |
| Metric | INVA | CET |
|---|---|---|
| Price | $21.41 | $52.50 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 727.2K | 39.1K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.12% |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 2.22 | N/A |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | $9.55 | ★ $6.93 |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $47.76 |
| 52 Week High | $25.15 | $54.65 |
| Indicator | INVA | CET |
|---|---|---|
| Relative Strength Index (RSI) | 41.01 | 44.48 |
| Support Level | $20.56 | $51.14 |
| Resistance Level | $22.86 | $52.29 |
| Average True Range (ATR) | 0.48 | 0.54 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 18.15 | 3.67 |
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Central Securities Corp is a non-diversified closed-end management investment company. The company's investment objective is long-term growth of capital. It invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.